Concepedia

Tadashi Koieyama

TK

5

Publications

500

Citations

5

H-Index

2002

Active since

Affiliations

Daiichi-Sankyo (Japan)(Current)

Daiichi Sankyo (Germany)

Tadashi Koieyama is an author at Daiichi-Sankyo (Japan) specializing in medicine, inflammation, and vascular biology.

Top concepts

Publications per year

2002–2011

5

Publications

5

T‐0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor‐deficient mice

Naoki Terasaka, Ayano Hiroshima, Tadashi Koieyama et al. · FEBS Letters · 2002 · 322 citations

Liver X receptor agonists inhibit tissue factor expression in macrophages

Naoki Terasaka, Ayano Hiroshima, Akiko Ariga et al. · FEBS Journal · 2005 · 67 citations · Full text

, , +20

ACAT inhibitor pactimibe sulfate (CS-505) reduces and stabilizes atherosclerotic lesions by cholesterol-lowering and direct effects in apolipoprotein E-deficient mice

Naoki Terasaka, Atsuhiro Miyazaki, Naomi Kasanuki et al. · Atherosclerosis · 2006 · 51 citations

, , +11

LXRα regulates human CETP expression in vitro and in transgenic mice

Shoko Honzumi, Akiko Shima, Ayano Hiroshima et al. · Atherosclerosis · 2010 · 36 citations

, , +10

Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits

Shoko Honzumi, Akiko Shima, Ayano Hiroshima et al. · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 2011 · 24 citations

, , +10

Rows per page

1–5 of 5